首页> 外文会议>International Conference on Bioscience and Bioinformatics >Synthesis and Characterization of Ruthenium Metal Complexes of Polydentate Pyridine-based Ligands
【24h】

Synthesis and Characterization of Ruthenium Metal Complexes of Polydentate Pyridine-based Ligands

机译:多弥敦法吡啶配体钌金属配合物的合成与表征

获取原文

摘要

Following the remarkable success of cisplatin as a chemotherapeutic drug for the treatment of various cancers [1], recent studies have shifted interest into the potential use of ruthenium-based complexes [2]. These complexes exhibit low toxicity and their effectiveness against cisplatin-resistant tumor cells has been well documented [3]. In quest of developing more effective and less toxic ruthenium-based anticancer agents, we report herein the synthesis and characterization of a series of Ru(III)-based complexes of polydentate pyridine-based ligands of the type, N,N,N',N'-tetrakis(2-pyridylmethyl)-1, n-diamine alkane where n = 2, 3,4,6,7 or 8. The effect of the ligand on the complexes was studied by varying the value of n and to establish the binding mode of the ligands, Ruthenium (III) complexes of the same ligand with different metal to ligand ratios were synthesized. Characterization of all synthesized complexes was done by FTIR, ~1H -NMR, ~(13)C- NMR spectroscopies, and Elemental Analysis. Hydrolytic behavior and interaction of these complexes with a model nucleobase were studied by UV-Vis spectroscopy, multidimensional ~1H-NMR spectroscopy and Thin Layer Chromatography. Interactions of the ligands and the metal complexes with calf thymus DNA (CT-DNA) were investigated using electronic absorption titrations.
机译:在顺铂作为治疗各种癌症的化学治疗药物的显着成功之后,最近的研究已经改变了钌基配合物的潜在使用[2]。这些配合物表现出低毒性,并且它们针对顺铂抗性肿瘤细胞的有效性已被良好记载[3]。在寻求培养更有效和较低的基于钌的抗癌剂中,我们在本文中报告了一系列ru(III)的合成和表征,基于类型的吡啶基配体的基于型吡啶基配体,N,N,N', N'-四甲基(2-吡啶基甲基)-1,N-二胺烷烃,其中N = 2,3,4,6,7或8.通过改变n的值和建立的值,研究了配体对复合物上的络合物的作用合成了配体的结合方式,具有不同金属与配体比的相同配体的钌(III)复合物。所有合成配合物的表征通过FTIR,〜1H-NMR,〜(13)C-NMR光谱和元素分析来完成。通过UV-Vis光谱,多维〜1H-NMR光谱和薄层色谱法研究了用模型核碱基与模型核碱基的水解行为和相互作用。使用电子吸收滴定研究了配体和金属配合物与CALF胸腺DNA(CT-DNA)的相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号